Clinical Trials
Welcome to the Low Grade Glioma Registry Clinical Trials finder. Our Registry team is working to help make it easier for our community to locate glioma clinical trials. Led by Yale LGG Registry co-investigator Dr. Kevin Hall and his colleagues at ARCHETYP, we have now developed a draft version here.
The data are obtained from ClinicalTrials.gov, an online database of clinical research studies. The National Library of Medicine (NLM) maintains the website. The study sponsor or investigator submits information about their study to ClinicalTrials.gov and is responsible for the safety, science, and accuracy of any study they list.
Please watch the following video to learn how to use our new finder:
What are clinical trials?
Clinical trials are research studies that assess the effects of new treatments or interventions on medical conditions. These studies involve patients and aim to advance treatments and improve patient outcomes.
Why are clinical trials important?
Clinical trials help scientists study the safety, efficacy (how well a disease responds to treatment), and effectiveness (how impactful a treatment is in more practical conditions) of novel treatments. Clinical trials are important in the process of ensuring new treatments can become available for future patients.
What factors should be considered before enrolling in a clinical trial?
Who runs the clinical trial?
Where is the clinical trial located?
Are you eligible to participate? For instance, do they place restrictions on age, co-morbidities, or other criteria?
Are there any costs to participate?
*It is important to consult your healthcare provider to thoroughly explore potential risks before enrolling in a trial.
Your feedback matters
Help us improve our clinical trials finder tool by going to the site and entering the data you wish to search on (i.e. IDH mutation, your age, etc). Please let us know what you think by contacting glioma@yale.edu.